Delivery Order SPE2DB20D2014-SPE2DB23FD19A
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of OxyContin ER 10 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,095.66 and a performance period through May 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OxyContin ER 10 mg tablets in 100-count bottles. The contract, valued at $1,223.67, was awarded on May 22, 2024 by the Defense Logistics Agency, a component of the Department of Defense, with a performance period ending on May 23, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of OxyContin ER 20 mg tablets. The contract is a Delivery Order valued at $1,941.97 with a firm fixed price and a completion date of March 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Oxycontin ER 10 mg tablets in quantities of 100s. The $1,039.46 delivery order contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed-price arrangement that will be fulfilled by December 11, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,850,528 Oxycontin ER 10 mg tablets in 100-count bottles. The $1,377.50 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 7, 2024, with a completion date of June 10, 2024. This award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) valued...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for Oxycontin ER 40 mg tablets. The $1,606.68 firm fixed price contract has a completion date of July 7, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows Amerisourcebergen to supply...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution firm Amerisourcebergen Corporation, is for the delivery of OxyContin ER 20 mg tablets to the Defense Logistics Agency (DLA). The firm fixed price delivery order has a potential value of $3,250.46 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. The company also holds an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 40 mg Oxycontin ER tablets in 100 count bottles. The contract has a completion date of April 5, 2024 and a ceiling value of $5,065.90. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Oxycontin ER 20 mg tablets. The $6,699.40 Firm Fixed Price Delivery Order contract has an ultimate completion date of July 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,806.50, is for the delivery of Oxycontin ER 40 mg tablets in quantities of 100s. This is a firm fixed-price Delivery Order contract with a period of performance through March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD19ADelivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Oxycontin ER 60 mg tablets. The contract, valued at $5,929.74, has an ultimate completion date of August 28, 2023 and was awarded on August 25, 2023 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order under a Firm Fixed Price type and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/25/23 |